Adrian Di Bisceglie

Biography

Dr. Di Bisceglie received his medical degree from the University of Witwatersrand, Johannesburg, South Africa in 1977 and completed his training in Internal Medicine at Baragwanath Hospital, Johannesburg (1981-1984) before doing his research fellowship at the National Institutes of Health (NIH) between 1986 and 1988. He went on to become a Senior Investigator, and then chief of the Liver Diseases Section, NIDDK. Dr. Di Bisceglie joined the faculty of Saint Louis University School of Medicine as Professor of Internal Medicine in 1994. Dr. Di Bisceglie is an internationally recognized expert in the field of viral hepatitis and liver disease and has published over 300 peer reviewed publications and has served on the editorial boards of many journals including Hepatology, Liver Transplantation and as Section Editor, Hepatitis C for UpToDate. He has served on many international and national committees including the Scientific Planning Committee for the 13th International Symposium on Viral Hepatitis and Liver Disease (2009), and has chaired the AASLD Public Policy and Clinical Research Committees. He was recently appointed to the Governing Board of AASLD. At the Food and Drug Administration he served as a member on the Blood Products Advisory Committee. He also serves as a member of the U.S. Hepatitis Panel for the U.S. Japan Cooperative Medical Sciences Program. Dr. Di Bisceglie has received numerous honors and awards, including the Fiterman Foundation Clinical Research in Hepatology or Nutrition (Hugh R. Butt) Award. He is currently is PI and Co-PI on several NIH sponsored grants and served as Chair, Steering Committee for the HALT-C Trial group from 1999-2011. At Saint Louis University, Dr. Di Bisceglie initially served as Associate Chairman for Education and residency program director (1994-1999). He has served on multiple institutional committees, including Curriculum Oversight Committee, the Governing Board of Saint Louis University Hospital (1998-2000) and more recently the Governing Board of the University Medical group. He was appointed as acting chairman of the Department of Internal Medicine in 2006 and then as chairman in May 2009.

Research Interest

Biopharma Sciences, Internal medicine, Hepatology